CompoAtlas

Girly 2

Natural health product licensed in Canada

Licence holder
Next Level Beauty Ltd.
NPN or DIN-HM
80056266
Status
Inactive licence
Licence date
4 December 2014
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Vitex agnus-castus

Source : Fruit

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 100 mg

Potency : 0.6 % Agnuside

10 mgNot calculated
L-théanine

Source : Camellia sinensis - feuille

100 mgNot calculated

Non-medicinal ingredients

Stéarate de magnésium, Hypromellose, Eau

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years2 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Formulated with Chasteberry extract, clinically proven to help reduce the symptoms of PMS (Pre Menstrual Syndrome) such as mood changes and irritability; clinically showen to help reduce sweet or salt cravings. Includes all-natural l-theanine which helps to provide a temporary feeling of relaxation.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80056266

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line